NCT05285865

Brief Summary

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 18, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

September 1, 2023

Status Verified

August 1, 2023

Enrollment Period

11 months

First QC Date

March 8, 2022

Last Update Submit

August 31, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Incentive Spirometer

    An incentive spirometer is a device that will expand the lungs by helping the patient breathe more deeply and fully

    1 week

  • Borg scale

    The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level.

    1 week

  • Numeric pain rating scale

    What is a numerical pain rating scale? The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain

    1 week

  • Digital Spirometer

    Spirometer is a portable lung function testing device, which mainly used to examine lung function related parameters for patients

    1 week

Study Arms (2)

Conventional Treatment

ACTIVE COMPARATOR

Thrice a day ,Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Other: Conventional Treatment

Scapular Mobilization

EXPERIMENTAL

Thrice a day Scapular mobilization (SM) along with Conventional treatment

Other: Scapular Mobilization

Interventions

Thrice a day for complete length of stay. This is Conventional treatment The total duration of session will be of 15-20 mins.

Conventional Treatment

Thrice a day for complete length of stay including two sets of repetitions with a rest interval of 30 seconds between sets. Grade 1-3 As reported in a study Scapular mobilization (SM) i.e., Scapular superior, inferior glides, upward and downward rotations and scapular distraction, along with Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Scapular Mobilization

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CAD patients undergone CABG surgery (Post-Op. Day#. 01).
  • Both genders (male and female).
  • Aged between 40 to 70 years .
  • Patient having oxygen saturation (SPO2) of more than or equal to 90% with 25% of fraction of inspired oxygen (FiO2) - (possibly nasal cannula inserted).

You may not qualify if:

  • Patients with low glasgow coma scale (GCS) score (less than 15).
  • Patients having inspiratory capacity of 3500ml and above.
  • Patients on ventilator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehman Medical Institute

Peshawar, KPK, 46000, Pakistan

Location

Study Officials

  • Malik Muhammad Ali Awan, MSPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2022

First Posted

March 18, 2022

Study Start

March 15, 2022

Primary Completion

February 10, 2023

Study Completion

July 1, 2023

Last Updated

September 1, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations